Apollon Wealth Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $781K | Buy |
9,990
+2,074
| +26% | +$162K | 0.02% | 625 |
|
|
2025
Q1 | $574K | Buy |
7,916
+645
| +9% | +$46.8K | 0.01% | 692 |
|
|
2024
Q4 | $538K | Sell |
7,271
-1,187
| -14% | -$87.9K | 0.01% | 723 |
|
|
2024
Q3 | $558K | Sell |
8,458
-4,283
| -34% | -$283K | 0.02% | 670 |
|
|
2024
Q2 | $1.18M | Sell |
12,741
-8,505
| -40% | -$786K | 0.04% | 418 |
|
|
2024
Q1 | $2.03M | Buy |
21,246
+189
| +0.9% | +$18.1K | 0.06% | 286 |
|
|
2023
Q4 | $1.61M | Buy |
21,057
+3,661
| +21% | +$279K | 0.06% | 314 |
|
|
2023
Q3 | $1.21M | Sell |
17,396
-1,109
| -6% | -$76.8K | 0.06% | 311 |
|
|
2023
Q2 | $1.75M | Buy |
18,505
+6,018
| +48% | +$568K | 0.08% | 239 |
|
|
2023
Q1 | $1.03M | Buy |
12,487
+119
| +1% | +$9.85K | 0.06% | 318 |
|
|
2022
Q4 | $923K | Buy |
12,368
+459
| +4% | +$34.2K | 0.07% | 325 |
|
|
2022
Q3 | $984K | Buy |
11,909
+77
| +0.7% | +$6.36K | 0.08% | 257 |
|
|
2022
Q2 | $1.13M | Buy |
11,832
+898
| +8% | +$85.4K | 0.09% | 234 |
|
|
2022
Q1 | $1.29M | Buy |
10,934
+1,452
| +15% | +$171K | 0.09% | 229 |
|
|
2021
Q4 | $1.23M | Buy |
9,482
+7,343
| +343% | +$951K | 0.09% | 239 |
|
|
2021
Q3 | $242K | Buy |
2,139
+46
| +2% | +$5.2K | 0.03% | 393 |
|
|
2021
Q2 | $217K | Buy |
+2,093
| New | +$217K | 0.04% | 337 |
|
|
2020
Q3 | – | Sell |
-559
| Closed | -$39K | – | 321 |
|
|
2020
Q2 | $39K | Buy |
+559
| New | +$39K | 0.02% | 279 |
|